HCV - Insulin Resistance / Diabetes
Statin and Diabetes Drug Show Activity against Hepatitis B Virus in Laboratory Studies 12-04-09 Sustained Response to Interferon-based Therapy Reduces Risk of Diabetes in Hepatitis C Patients 4/21/09 Insulin-sensitizing Agent Pioglitazone (Actos) Did Not Improve Response to Re-treatment with Pegylated Interferon plus Ribavirin 8/29/2008 Obesity and Diabetes Are Linked to Increased Risk of Liver Cancer 7/18/08 Insulin Resistance and Diabetes Increase the Risk of Liver Fibrosis and Hepatocellular Carcinoma in People with Chronic Hepatitis C 7/04/08 Sustained Response to Interferon-based Therapy Reduces the Likelihood of Type 2 Diabetes 6/24/08 Insulin Resistance and Diabetes Increase the Risk of Liver Fibrosis and Hepatocellular Carcinoma in People with Chronic Hepatitis C 6/24/08 Sustained Response to Interferon-based Therapy Reduces the Likelihood of Type 2 Diabetes 6/24/08 Insulin Resistance is a Risk Factor for Liver Fibrosis Even without Steatosis 2/29/08 Insulin Resistance Linked to Lower Treatment Response in Genotype 2/3 Patients 2/01/08
Cirrhosis Fibrosis Hepatocellular Carcinoma Liver Transplantation Liver Biopsy Steatosis Anemia Chilren / Infants / Women Drug Abuse Experimental Treatments FAQs About Hepatitis C Genotypes Insulin Resistance / Diabetes Sustained Viral Response (SVR) Tests for HCV Vaccines for HCV
